Biomarkers of Prognosis and Efficacy of Anti-angiogenic Therapy in Metastatic Clear Cell Renal Cancer

In the last decades, the prognosis of metastatic renal cell carcinoma (mRCC) has remarkably improved following the advent of the “targeted therapy” era. The expanding knowledge on the prominent role played by angiogenesis in RCC pathogenesis has led to approval of multiple anti-angiogenic agents suc...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Oncol
Main Authors: D'Aniello, Carmine, Berretta, Massimiliano, Cavaliere, Carla, Rossetti, Sabrina, Facchini, Bianca Arianna, Iovane, Gelsomina, Mollo, Giovanna, Capasso, Mariagrazia, Pepa, Chiara Della, Pesce, Laura, D'Errico, Davide, Buonerba, Carlo, Di Lorenzo, Giuseppe, Pisconti, Salvatore, De Vita, Ferdinando, Facchini, Gaetano
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6917607/
https://ncbi.nlm.nih.gov/pubmed/31921657
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.01400
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares